Zde se nacházíte:
Informace o publikaci
PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in mice
Autoři | |
---|---|
Rok publikování | 2019 |
Druh | Článek v odborném periodiku |
Časopis / Zdroj | Nature Communications |
Fakulta / Pracoviště MU | |
Citace | |
www | https://www.nature.com/articles/s41467-019-09180-3 |
Doi | http://dx.doi.org/10.1038/s41467-019-09180-3 |
Klíčová slova | CANCER GENE DISCOVERY; SLEEPING-BEAUTY; CHROMOSOMAL TRANSPOSITION; INSERTIONAL MUTAGENESIS; THERAPEUTIC TARGETS; CODING GENOME; MOUSE MODEL; PATHOGENESIS; ACTIVATION; MUTATION |
Popis | B-cell lymphoma (BCL) is the most common hematologic malignancy. While sequencing studies gave insights into BCL genetics, identification of non-mutated cancer genes remains challenging. Here, we describe PiggyBac transposon tools and mouse models for recessive screening and show their application to study clonal B-cell lymphomagenesis. In a genome-wide screen, we discover BCL genes related to diverse molecular processes, including signaling, transcriptional regulation, chromatin regulation, or RNA metabolism. Cross-species analyses show the efficiency of the screen to pinpoint human cancer drivers altered by non-genetic mechanisms, including clinically relevant genes dysregulated epigenetically, transcriptionally, or post-transcriptionally in human BCL. We also describe a CRISPR/Cas9-based in vivo platform for BCL functional genomics, and validate discovered genes, such as Rfx7, a transcription factor, and Phip, a chromatin regulator, which suppress lymphomagenesis in mice. Our study gives comprehensive insights into the molecular landscapes of BCL and underlines the power of genome-scale screening to inform biology. |